Format

Send to

Choose Destination
Med Clin North Am. 2017 Jul;101(4):673-688. doi: 10.1016/j.mcna.2017.03.002.

Cardiovascular Risk Assessment.

Author information

1
Departments of Epidemiology & Biostatistics and Medicine, University of California, San Francisco, 550 16th Street, Mission Hall 2nd Floor, San Francisco, CA 94143-0560, USA. Electronic address: mpletcher@epi.ucsf.edu.
2
Division of General Medicine, Presbyterian Hospital, Columbia University Medical Center, 630 West 168th Street, 9th Floor East, Room 105, New York, NY 10032, USA.

Abstract

Cardiovascular risk assessment is fundamental to prevention of cardiovascular disease, because it helps determine the size of the potential benefits that might accrue to individual patients from use of statins, aspirin, and other preventive interventions. Current guidelines recommend specific algorithms for cardiovascular risk assessment that combine information from traditional risk factors including blood pressure, lipids, and smoking, along with age and sex and other factors. These algorithms are the subject of active research and controversy. This article addresses the rationale, current guidelines and use, and potential future directions of cardiovascular risk assessment.

KEYWORDS:

Biomarkers; Cardiovascular disease prevention; Cardiovascular risk; Risk factors; Risk prediction

PMID:
28577619
DOI:
10.1016/j.mcna.2017.03.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center